Follicular thyroid cancer: Difference between revisions
CSV import |
CSV import |
||
| Line 30: | Line 30: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Follicular_thyroid_carcinoma_2_--_low_mag.jpg|Follicular thyroid cancer | |||
File:Hurthle_cell_neoplasm.jpg|Hurthle cell neoplasm | |||
</gallery> | |||
Revision as of 01:50, 18 February 2025
Follicular thyroid cancer is a type of thyroid cancer that originates from the follicular cells of the thyroid gland. It is the second most common type of thyroid cancer, accounting for approximately 10-15% of all thyroid cancer cases.
Symptoms
Follicular thyroid cancer often does not cause any symptoms in its early stages. However, as the cancer grows, it may cause symptoms such as a lump in the neck, difficulty swallowing, changes in the voice, and neck pain.
Causes
The exact cause of follicular thyroid cancer is unknown. However, it is believed to be associated with certain risk factors, including age, gender, exposure to radiation, and a family history of thyroid disease or cancer.
Diagnosis
The diagnosis of follicular thyroid cancer is often made through a combination of physical examination, blood tests, imaging tests, and a biopsy of the thyroid gland.
Treatment
The treatment for follicular thyroid cancer typically involves surgery to remove the thyroid gland, followed by radioactive iodine therapy to destroy any remaining cancer cells. Other treatments, such as hormone therapy, chemotherapy, and targeted therapy, may also be used in certain cases.
Prognosis
The prognosis for follicular thyroid cancer is generally good, with a 5-year survival rate of over 90% for localized disease. However, the prognosis can vary depending on the stage of the disease, the patient's age, and other factors.
See also
References
<references />


